Motus GI Holdings Inc (MOTS) Receives Average Recommendation of “Buy” from Analysts
Shares of Motus GI Holdings Inc (NASDAQ:MOTS) have earned a consensus rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $10.63.
MOTS has been the subject of a number of recent analyst reports. EuroPacific Canada initiated coverage on Motus GI in a research note on Thursday, May 31st. They issued a “buy” rating and a $12.00 price objective for the company. ValuEngine raised Motus GI from a “hold” rating to a “buy” rating in a research note on Wednesday, July 4th. Oppenheimer set a $10.00 price objective on Motus GI and gave the stock a “buy” rating in a research note on Friday, July 13th. Zacks Investment Research lowered Motus GI from a “hold” rating to a “sell” rating in a research note on Wednesday, July 18th. Finally, Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $8.00 price objective on shares of Motus GI in a research note on Tuesday, August 14th.
A number of institutional investors have recently made changes to their positions in the stock. Highbridge Capital Management LLC bought a new position in Motus GI during the first quarter valued at approximately $896,000. Hilltop Holdings Inc. bought a new position in Motus GI during the first quarter valued at approximately $502,000. Quantitative Systematic Strategies LLC bought a new position in Motus GI during the second quarter valued at approximately $113,000. Finally, IPG Investment Advisors LLC bought a new position in Motus GI during the second quarter valued at approximately $106,000. 21.61% of the stock is owned by institutional investors.
Motus GI (NASDAQ:MOTS) last released its quarterly earnings data on Tuesday, August 14th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.01). The firm had revenue of $0.03 million during the quarter. sell-side analysts forecast that Motus GI will post -1.01 earnings per share for the current fiscal year.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
See Also: How a Put Option Works
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.